Safety · 2026-05-01
NPR Report: Synthetic Kratom Products Now "More Potent Than Fentanyl," Doctors Warn of Emerging Opioid Crisis
Source: WESA / WHYY (NPR)
Why it matters
Clinicians and addiction specialists are raising alarms that products sold as "kratom" increasingly contain synthetic derivatives like 7-OH and mitragynine pseudoindoxyl that bear no resemblance to the original plant and carry risks comparable to potent opioids—with patients presenting in ERs with classic opioid withdrawal and overdose patterns.
The big picture
The kratom market has evolved through three waves: traditional leaf powder, "enhanced" products with concentrated 7-OH, and now fully synthetic derivatives like mitragynine pseudoindoxyl. While traditional kratom caused few fatalities, kratom-related poison center calls have surged 1,200% since 2015, driven largely by this product evolution. Addiction experts now describe the situation as resembling the early prescription opioid epidemic.
Key findings
- Philadelphia ER physician Dr. Jeanmarie Perrone treated a 7-OH patient whose full opioid withdrawal resolved immediately with a single dose of buprenorphine
- Mitragynine pseudoindoxyl, a synthetic derivative sold as kratom, is described as "more potent than fentanyl" by addiction psychiatrists
- Kratom poisonings have surged 1,200% since 2015, according to a CDC report, driven by third-wave synthetic products
- Patients are advancing from kratom to 7-OH to mitragynine pseudoindoxyl in search of increasing potency, with severe withdrawal upon discontinuation
- Experts note products sold as "kratom" now often contain compounds not found in the kratom plant, creating consumer confusion and regulatory challenges
What they say
"Currently, the market is basically a Wild West," said Dartmouth addiction psychiatrist Dr. Corneliu Stanciu. "You have everything out there being called kratom, even though it's not kratom."
Bottom line
NPR/WHYY's in-depth investigation reveals that synthetic kratom derivatives, particularly 7-OH and mitragynine pseudoindoxyl, have created a third wave of potent, unregulated opioid-like substances sold as kratom—prompting emergency physicians to treat them the same as traditional opioid use disorder.